PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Menthol→

Menthol PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
89-78-1
Molecular formula
C10H20O
Molecular weight
156.2652 g/mol
Drug class
Topical counterirritanttransient receptor potential melastatin 8 (TRPM8) agonist
Mechanism of action
Activates TRPM8 cold-sensing ion channels in cutaneous sensory neurons, producing a cooling sensation and counterirritant effect that can temporarily reduce perception of superficial pain or itching. Additional effects on sensory signalling depend on concentration and formulation.
Indications / reported uses
  • Temporary relief of minor muscle and joint aches and pains in topical external analgesic preparations
  • Symptomatic relief of minor throat irritation or cough in selected lozenges and topical preparations; route and formulation-specific labels apply

Sources: US eCFR — External analgesic drug products, 21 CFR Part 348 · NLM MeSH — Menthol · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Menthol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Menthol Permitted Daily Exposure (PDE) report (the Menthol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Menthol Occupational Exposure Limit (OEL) report (the Menthol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.